Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.

Ang EL, Chan WL, Cleland JG, Moore D, Krikler SJ, Alexander ND, Oakley CM.

Br Heart J. 1990 Oct;64(4):256-60.

2.

Xamoterol improves the control of chronic atrial fibrillation in elderly patients.

Lawson-Matthew PJ, McLean KA, Dent M, Austin CA, Channer KS.

Age Ageing. 1995 Jul;24(4):321-5.

PMID:
7484490
3.
5.
6.

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.

DiBianco R, Morganroth J, Freitag JA, Ronan JA Jr, Lindgren KM, Donohue DJ, Larca LJ, Chadda KD, Olukotun AY.

Am Heart J. 1984 Oct;108(4 Pt 2):1121-7.

PMID:
6148872
7.

Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.

Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK, et al.

Int J Cardiol. 1995 Nov 24;52(2):167-74.

PMID:
8749878
8.

Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.

Virk SJ, Qiang FX, Anfilogoff NH, Murray RG, Littler WA, Davies MK.

Am J Cardiol. 1991 May 6;67(12):48C-52C; discussion 52C-54C.

PMID:
1673587
9.

The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.

Virk SJ, Anfilogoff NH, Lawson N, Qiang F, Murray RG, Littler WA, Davies MK.

Eur Heart J. 1990 Oct;11(10):876-84.

PMID:
1979946
10.
11.

Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.

Waller DG, Webster J, Sykes CA, Bhalla KK, Wray R.

Eur Heart J. 1989 Nov;10(11):1003-10.

PMID:
2574108
12.

[Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].

Vitale P, Auricchio A, De Stefano R, Agretto A, De Simone R, Vitale N, Barbato F, Iacono A.

Cardiologia. 1989 Jan;34(1):73-81. Italian.

PMID:
2720716
13.

Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.

Channer KS, James MA, MacConnell T, Rees JR.

Br J Clin Pharmacol. 1994 Jan;37(1):53-7.

14.

Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.

Kochiadakis GE, Kanoupakis EM, Kalebubas MD, Igoumenidis NE, Vardakis KE, Mavrakis HE, Vardas PE.

Europace. 2001 Jan;3(1):73-9.

15.

[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].

Fukuda K, Handa S, Ogawa S, Nakamura Y, Kawamura Y.

J Cardiol. 1990;20(3):755-65. Japanese.

PMID:
2151866
17.

Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation.

Zoble RG, Brewington J, Olukotun AY, Gore R.

Am J Cardiol. 1987 Aug 31;60(6):39D-45D.

PMID:
3307366
18.
20.

Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation.

Kochiadakis GE, Kanoupakis EM, Igoumenidis NE, Mavrakis HE, Kafarakis PK, Vardas PE.

Hellenic J Cardiol. 2005 Sep-Oct;46(5):336-40.

Items per page

Supplemental Content

Support Center